The post-doc will work in the research group of prof. dr. Rob Collin, at the Department of Human Genetics at the Radboud university medical center in Nijmegen, The Netherlands. The group consists of appx. ten employees, including post-docs, PhD candidates, technicians and MSc / Bsc students, all dedicated to design and develop therapeutic interventions for patients that are visually impaired, with the incentive to prevent them from getting blind.

The group maintains close collaborations with other research groups and disciplines (e.g., the Department of Ophthalmology at Radboudumc), inside The Netherlands (Lifelong Vision consortium) as well as internationally.

We are looking for an enthusiastic colleague with strong communication skills, strong problem-solving skills and that is able to work independently as well as within a team.

Applicants should hold a PhD in Molecular Life Sciences, ideally related to the development of molecular therapies and/or retinal research. In case the PhD has not yet been completed, the PhD manuscript should at least be submitted to the reading / evaluation committee before the employment starts. Clearly state your (anticipated) date of defense / thesis manuscript submission in your CV and/or motivation letter.

Experience with retinal research, molecular therapies (antisense oligonucleotides or CRISPR/Cas9), culturing iPSC-derived (retinal) organoids, and/or working with zebrafish are considered a strong plus.

• The first job interviews will take place in the 2nd half of September 2026. The second round of interviews will occur in the 1st half of October 2026. Please take this into account.
• This position requires a Certificate of Conduct (VOG).

We are recruiting for this position ourselves. Unsolicited marketing is not appreciated, but do feel free to share the vacancy in your network!